Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02484547 |
|---|---|
| Brief Title: | 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (EMERGE) |
| First Submitted : | June 18, 2015 |
| First Submitted that Met QC Criteria : | June 26, 2015 |
| First Posted : | June 29, 2015 (Estimate) |
| Results First Submitted : | July 1, 2021 |
| Results First Submitted that Met QC Criteria : | August 9, 2021 |
| Results First Posted : | September 2, 2021 |
| Certification/Extension First Submitted : | August 4, 2020 |
| Certification/Extension First Submitted that Met QC Criteria : | August 4, 2020 |
| Certification/Extension First Posted : | August 5, 2020 |
| Last Update Submitted that Met QC Criteria : | August 9, 2021 |
| Last Update Posted : | September 2, 2021 |